Osaka, Japan

Hiroki Ohshima

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Mineralys Therapeutics, Inc., Tanabe Pharma Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroki Ohshima. Retrieved from https://idiyas.com/inventor/hiroki-ohshima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroki Ohshima: Pharmaceutical Composition Inventor

Introduction

Hiroki Ohshima is an inventor associated with Osaka, Japan. His patent work concerns pharmaceutical formulations designed to preserve the properties of an active compound’s salt.

Latest Patents

Ohshima is named on one patent, titled “Soluble Pharmaceutical Compositions Comprising Salts of Disubstituted 1,2,4-Triazine Compound.” The patent describes compositions containing a salt of a disubstituted 1,2,4-triazine compound and one or more excipients. The formulation is designed to avoid inducing disproportionation of the compound’s salt. His listed patent portfolio includes 1 patent.

Career Highlights

Ohshima has been associated with Mineralys Therapeutics, Inc. and Tanabe Pharma Corporation. His patent reflects work in pharmaceutical composition design and formulation stability.

Collaborations

Roch Thibert and Yoshinori Ohashi are listed among Ohshima’s coworkers, connecting his professional profile with colleagues in the pharmaceutical field.

Conclusion

Hiroki Ohshima’s recorded invention focuses on a soluble pharmaceutical composition intended to prevent salt disproportionation, alongside career associations with Mineralys Therapeutics and Tanabe Pharma.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…